Collectively, these studies demonstrate that HGF and its receptor are strong therapeutic targets for cancer treatment and investigation of factors that govern the influence of HGF/c-Met coupling may lead to novel strategies to combat the metastatic spread of tumours. The gene discussed is MET; the disease is cancer.